Enteric Disease Testing Market

Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026

Report Code: FB 7970 Aug, 2021, by marketsandmarkets.com

[273 Pages Report] The enteric disease testing market is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must be increased by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market with an increasing number of enteric disease controls in each step—from the raw material procurement till the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.

Enteric Disease Testing Market

COVID-19 Impact on the Global Enteric disease testing Market

The concern among consumers is estimated to increase for the security and safety of food products due to the outbreak of COVID-19, and this might lead to a high adoption rate for testing technologies and laboratories across the globe. Thus, the demand for enteric disease testing will increase in the coming years. Moreover, pandemic situations created due to the outbreak of COVID-19 will increase the demand for rapid tests from food manufacturers and growers to test an adequate number of samples in less time, thereby increasing the supply chain activities and enhancing the adoption of testing technologies.

Enteric disease testing Market Dynamics

Driver: Increase in demand for convenience foods

Busy lifestyles have slowly shifted consumer focus from traditional buying of raw food products to convenience and packaged food products, such as frozen foods and ready-to-eat (RTE) meals. For higher marketability, additives are used to accentuate the organoleptic characteristics of food & beverages. Packaged products are also added with preservatives to improve their shelf life. With the increase in preference for convenience foods, the need for enteric disease testing is growing.

Restraint: Lack of proper regulations governing pathogen testing in the developing economies

The food industry in developing countries remains highly fragmented and is predominated by small and unorganized players, who may have not necessarily adopted proper food testing practices, leading to a greater risk of contamination. The testing of food & beverage products, such as packaged foods, dairy products, beverages, and meat products, requires proper enforcement measures, coordination between market stakeholders, and supporting infrastructure. However, many countries that are classified in the cluster of developing economies lack these factors, acting as a restraint to the testing of pathogens in food and water in these regions.

Opportunity: Technological innovations in the enteric disease testing industry

Technological advancements and innovation across the supply chain have brought about a change in the way business is conducted. The focus is on reducing the lead time, sample utilization, the overall cost of testing services offered. Cheaper, faster, and efficient computing hardware coupled with improved software, network connectivity, and advanced sensors is gaining traction in the enteric disease industry.

Challenge: High cost associated with the testing of food and water

Automated testing instruments are equipped with advanced features and functionalities and are thus priced at a premium. For example, the price for spectroscopy-based systems ranges from USD 150,000 to USD 850,000. The estimated cost for the instrument, media, and labor is also very high for some end users. Testing laboratories require many such systems, owing to which the entire capital cost investment increases significantly.

Market Ecosystem

Enteric Disease Testing Market Ecosystem

To know about the assumptions considered for the study, download the pdf brochure

The food segment is estimated to account for the fastest growth in the by end use segment for the enteric disease testing market.

The increase in food trade has encouraged public health and government agencies to continuously monitor food quality and take prompt actions to identify, contain, and correct sources of outbreaks. For instance, the Enteric disease and Inspection Service (FSIS) has framed regulations to control the contamination of meat & poultry products in slaughterhouses and processing plants, based on the HACCP enteric disease control system.

By technology, the rapid technology segment is estimated to account for the largest market share in the enteric disease testing market.

Rapid technology in the food industry is used to monitor the count, type, and metabolites of microorganisms that lead to food spoilage, preservation, fermentation, safety, and foodborne pathogens As the use of the Hazard Analysis & Critical Control Points (HACCP) model and other enteric disease systems have become firmly entrenched in quality assurance/quality control (QA/QC) programs, the industry’s need for “faster, better, cheaper” real-time test results has also increased.

The meat, poultry and seafood food sub-segment is estimated to account for the largest market share in the by food end use segment of enteric disease testing market over the forecast period.

The global consumption of meat and processed meat products is highly rising. Further, with expanding globalization, food products are traded, which provides scope for various processes ranging from packaging, handling, storing and transportation, leading to food infestation. All these factors lead to an increased chance of contamination of the food, due to which the meat and seafood products are estimated to account for the highest market share in the market.

Enteric Disease Testing Market by Region

The rising health awareness among consumers in the North American region and presence of key players is projected to account for the largest market size during the forecast period

The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.

Key Market Players

Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TάV SάD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size estimation

2016–2026

Base year considered

2020

Forecast period considered

2021–2026

Units considered

Value (USD)

Segments covered

Pathogen, technology, end use and Region

Regions covered

North America, Asia Pacific, Europe, South America, and RoW

Companies studied

Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Bureau Veritas (France), Intertek (UK), Romer Labs (Austria), Mιrieux NutriSciences (US), TάV SάD (Germany), Bio-Rad Laboratories, Inc. (US), PerkinElmer, Inc. (US), Becton Dickinson (US), 3M (US), AsureQuality (New Zealand), Certified Laboratories (US), ALS Limited (Australia), Symbio Laboratories (Australia), Neogen Corporation (US), Nova Biologicals (US), and Hardy Diagnostics (US).

This research report categorizes the enteric disease testing market based on pathogen, technology, end use and region.

On the basis of pathogen tested, the enteric disease testing market has been segmented as follows:

  • E. coli
  • Salmonella
  • Campylobacter
  • Listeria
  • Other pathogens (include Enterobacteriaceae; Shigella; Norovirus; Clostridium; Hepatitis A, B, and E; Rotavirus; and Vibrio)

On the basis of technology, the enteric disease testing market has been segmented as follows:

  • Traditional
  • Rapid
  • Convenience-based
  • Polymerase chain reaction (PCR)
  • Immunoassay
  • Chromatography & spectrometry

On the basis of end use, the enteric disease testing market has been segmented as follows:

  • Water
  • Food
    • Meat, poultry, and seafood
    • Dairy products
    • Processed food
    • Fruits & vegetables
    • Other food products (includes nuts, herbs & spices, and cereals & grain)

On the basis of region, the enteric disease testing market has been segmented as follows:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Rest of the World (RoW) (includes South Africa and the Middle East

Recent Developments

  • In June 2021, SGS announced the official opening of Its new food testing laboratory in Papua New Guinea, which would offer internationally recognized quality testing to the food manufacturing, hospitality, and retail market segments.
  • In February 2021, Thermo Fisher Scientific, Inc. acquired Mesa Biotech (US), which aims at expanding the benefits of molecular diagnostics at hospitals.
  • In July 2021, Intertek acquired JLA Brazil, a market-leading independent provider of food, agri, and environmental testing solutions. The acquisition of JLA offered an opportunity to Intertek to enter the fast-growing food testing sector in Brazil, one of the largest markets globally in terms of agri-food & beverage production value.
  • In October 2018, the acquisition of EnvironeX Group Inc. (Canada), a provider of testing services to the environment, agriculture, food, and health & pharmaceuticals sectors with three laboratories, was undertaken by Eurofins to expand its presence in the Canadian market.
  • In May 2018, Eurofins set up a new 3,900 square meter food testing laboratory in Suzhou (China). This new laboratory highlighted its commitment to serve its clients in Asia Pacific with world-class testing services. This project represents a total investment of close to USD 3.3 million.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE
           FIGURE 1 ENTERIC DISEASE TESTING MARKET SEGMENTATION
           1.3.1 REGIONAL SEGMENTATION
    1.4 INCLUSIONS & EXCLUSIONS
           1.4.1 PERIODIZATION CONSIDERED
    1.5 CURRENCY CONSIDERED
           TABLE 1 USD EXCHANGE RATES, 2015–2019
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
           FIGURE 2 ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key industry insights
                    2.1.2.2 Breakdown of primary interviews
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
                    FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY APPROACH
    2.3 DATA TRIANGULATION
           FIGURE 5 DATA TRIANGULATION METHODOLOGY
           2.3.1 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE
                    FIGURE 6 MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 2020
           2.3.2 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE
    2.4 RESEARCH ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS
    2.6 MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-19
    2.7 SCENARIO-BASED MODELLING
    2.8 COVID-19 HEALTH ASSESSMENT
           FIGURE 7 COVID-19: GLOBAL PROPAGATION
           FIGURE 8 COVID-19 PROPAGATION: SELECT COUNTRIES
    2.9 COVID-19 ECONOMIC ASSESSMENT
           FIGURE 9 REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020
           2.9.1 COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT
                    FIGURE 10 CRITERIA IMPACTING GLOBAL ECONOMY
                    FIGURE 11 SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY

3 EXECUTIVE SUMMARY (Page No. - 51)

4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET
    4.2 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY
    4.3 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
           FIGURE 18 SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 2020
    4.4 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
    4.5 ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT
    4.6 ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS

5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION
    5.2 MACROECONOMIC INDICATORS
           5.2.1 INCREASE IN FOODBORNE ILLNESSES
                    FIGURE 22 NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION)
                    FIGURE 23 US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 2020
    5.3 MARKET DYNAMICS
           FIGURE 24 ENTERIC DISEASE TESTING MARKET DYNAMICS
           5.3.1 DRIVERS
                    5.3.1.1 Increase in the number of food recalls
                               FIGURE 25 EU: NUMBER OF FOOD RECALLS, 2017–2020
                               FIGURE 26 US: REASONS FOR RECALL OF FOOD, 2020
                    5.3.1.2 Rise in demand for convenience foods
                               FIGURE 27 READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 2020
                               FIGURE 28 RISE IN GLOBAL MEAT EXPORTS, 2017–2020 (KT)
                    5.3.1.3 Increase in global trade owing to higher disposable income among consumers
                               FIGURE 29 GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY, 2016–2018 (USD BILLION)
                               FIGURE 30 COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION)
           5.3.2 RESTRAINTS
                    5.3.2.1 Lack of proper regulations governing pathogen testing in the developing economies
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Technological innovations in the food safety testing industry
                    5.3.3.2 R&D investment directed toward the development of PCR technology for improved pathogen testing
                               TABLE 2 R&D INVESTMENT BY MAJOR COMPANIES
           5.3.4 CHALLENGES
                    5.3.4.1 High cost associated with testing of food and water

6 INDUSTRY TRENDS (Page No. - 66)
    6.1 INTRODUCTION
    6.2 REGULATORY FRAMEWORK
           6.2.1 INTRODUCTION
           6.2.2 INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS
                    6.2.2.1 Codex Alimentarius Commission (CAC)
                    6.2.2.2 Global Food Safety Initiative (GFSI)
           6.2.3 NORTH AMERICA
                    6.2.3.1 US regulations
                    6.2.3.2 Mexico
                    6.2.3.3 Canada
           6.2.4 EUROPE
                    6.2.4.1 Microbiological criteria regulation
                    6.2.4.2 General food law for food safety
                    6.2.4.3 Germany
                    6.2.4.4 UK
                    6.2.4.5 France
                    6.2.4.6 Italy
                    6.2.4.7 Poland
           6.2.5 ASIA PACIFIC
                    6.2.5.1 China
                               TABLE 3 PATHOGEN LIMITS FOR FOOD
                    6.2.5.2 India
                    6.2.5.3 Japan
                    6.2.5.4 Australia
                    6.2.5.5 New Zealand
           6.2.6 SOUTH AMERICA
                    6.2.6.1 Brazil
                    6.2.6.2 Ministry of Agriculture, Livestock, and Food Supply (MAPA)
                    6.2.6.3 Ministry of Health (MS)
                    6.2.6.4 Argentina
    6.3 PORTER’S FIVE FORCES ANALYSIS
           TABLE 4 ENTERIC DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
           6.3.1 THREAT OF NEW ENTRANTS
           6.3.2 THREAT OF SUBSTITUTES
           6.3.3 BARGAINING POWER OF SUPPLIERS
           6.3.4 BARGAINING POWER OF BUYERS
           6.3.5 DEGREE OF COMPETITION
    6.4 MARKET ECOSYSTEM
           FIGURE 31 ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP
           6.4.1 UPSTREAM
           6.4.2 DOWNSTREAM
                    TABLE 5 COMPANY MARKET ECOSYSTEM
    6.5 SUPPLY CHAIN ANALYSIS
           FIGURE 32 REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET
           6.5.1 R&D
           6.5.2 PRODUCTION
           6.5.3 PROCESSING & TRANSFORMING
           6.5.4 TRANSPORTATION
           6.5.5 FINAL PREPARATION
           6.5.6 DISTRIBUTION
    6.6 TECHNOLOGY ANALYSIS
    6.7 PATENT ANALYSIS
           FIGURE 33 PATENT ANALYSIS, 2017-2020
           TABLE 6 KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET, 2018- 2021
    6.8 CASE STUDIES
           TABLE 7 AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION
    6.9 DISRUPTIONS IMPACTING BUYERS IN THE MARKET
           FIGURE 34 THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES
    6.10 IMPACT OF COVID-19 ON MARKET DYNAMICS
           6.10.1 COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT
           6.10.2 COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY

7 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN (Page No. - 88)
    7.1 INTRODUCTION
           FIGURE 35 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021 VS. 2026 (USD MILLION)
           TABLE 8 PATHOGENESIS OF COMMON PATHOGENS
           FIGURE 36 US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 2019
           TABLE 9 US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 2019
           TABLE 10 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
           TABLE 11 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
           7.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
                    7.1.1.1 Realistic Scenario
                               TABLE 12 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
                               TABLE 13 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
                    7.1.1.2 Optimistic Scenario
                               TABLE 14 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
                               TABLE 15 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
                    7.1.1.3 Pessimistic Scenario
                               TABLE 16 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
                               TABLE 17 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
           7.1.2 E. COLI
                    7.1.2.1 Proper food safety testing can limit the incidences of E. coli food poisoning
                               FIGURE 37 US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009–2018
                               FIGURE 38 TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI)
                               TABLE 18 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                               TABLE 19 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
           7.1.3 SALMONELLA
                    7.1.3.1 Salmonella foodborne infection is found to be severe during summer than in winter
                               FIGURE 39 US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009–2018
                               TABLE 20 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                               TABLE 21 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
           7.1.4 CAMPYLOBACTER
                    7.1.4.1 WHO is strengthening disease surveillance to prevent foodborne illness
                               FIGURE 40 US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009–2018
                               TABLE 22 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                               TABLE 23 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
           7.1.5 LISTERIA
                    7.1.5.1 L. monocytogenes causes high hospitalization rate than any other foodborne pathogen
                               TABLE 24 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                               TABLE 25 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
           7.1.6 OTHER PATHOGENS
                    TABLE 26 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                    TABLE 27 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)

8 ENTERIC DISEASE TESTING MARKET, BY END USE (Page No. - 103)
    8.1 INTRODUCTION
           FIGURE 41 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019
           FIGURE 42 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021 VS. 2026 (USD MILLION)
           TABLE 28 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
           TABLE 29 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
           TABLE 30 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
           TABLE 31 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
           8.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE
                    8.1.1.1 Realistic scenario
                               TABLE 32 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                               TABLE 33 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                    8.1.1.2 Optimistic scenario
                               TABLE 34 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,  BY END USE, 2016–2020 (USD MILLION)
                               TABLE 35 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                    8.1.1.3 Pessimistic scenario
                               TABLE 36 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                               TABLE 37 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
    8.2 FOOD
           8.2.1 MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING
                    TABLE 38 ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS
                    FIGURE 43 EU: FOODBORNE DISEASE OUTBREAKS, 2017
                    TABLE 39 EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES
                    TABLE 40 US: FOOD RECALLS, 2020
                    TABLE 41 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2016–2020 (USD MILLION)
                    TABLE 42 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 43 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2016–2020 (USD MILLION)
                    TABLE 44 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2021–2026 (USD MILLION)
           8.2.2 MEAT, POULTRY, AND SEAFOOD
                    8.2.2.1 Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination
                               FIGURE 44 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019
                               TABLE 45 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016–2020 (USD MILLION)
                               TABLE 46 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021–2026 (USD MILLION)
                               TABLE 47 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2016–2020 (USD MILLION)
                               TABLE 48 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2021–2026 (USD MILLION)
           8.2.3 DAIRY PRODUCTS
                    8.2.3.1 Unhygienic storage conditions lead to contamination of dairy products
                               FIGURE 45 EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019
                               TABLE 49 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016–2020 (USD MILLION)
                               TABLE 50 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021–2026 (USD MILLION)
                               TABLE 51 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2016–2020 (USD MILLION)
                               TABLE 52 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2021–2026 (USD MILLION)
           8.2.4 PROCESSED FOOD
                    8.2.4.1 Ready-To-Eat foods are gaining more traction among consumers
                               TABLE 53 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016–2020 (USD MILLION)
                               TABLE 54 ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD, BY REGION, 2021–2026 (USD MILLION)
                               TABLE 55 ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016–2020 (USD MILLION)
                               TABLE 56 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS, BY PATHOGEN, 2021–2026 (USD MILLION)
           8.2.5 FRUITS & VEGETABLES
                    8.2.5.1 Good handling practices can help in the safe production of fresh produce
                               TABLE 57 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2016–2020 (USD MILLION)
                               TABLE 58 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2021–2026 (USD MILLION)
                               TABLE 59 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2016–2020 (USD MILLION)
                               TABLE 60 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2021–2026 (USD MILLION)
           8.2.6 OTHER FOOD APPLICATIONS
                    TABLE 61 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2016–2020 (USD MILLION)
                    TABLE 62 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 63 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2016–2020 (USD MILLION)
                    TABLE 64 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2021–2026 (USD MILLION)
    8.3 WATER
           8.3.1 POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS
                    TABLE 65 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2016–2020 (USD MILLION)
                    TABLE 66 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 67 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2016–2020 (USD MILLION)
                    TABLE 68 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2021–2026 (USD MILLION)

9 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY (Page No. - 126)
    9.1 INTRODUCTION
           FIGURE 46 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
           TABLE 69 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
           TABLE 70 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
           9.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
                    9.1.1.1 Realistic scenario
                               TABLE 71 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
                               TABLE 72 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
                    9.1.1.2 Optimistic scenario
                               TABLE 73 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
                               TABLE 74 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
                    9.1.1.3 Pessimistic scenario
                               TABLE 75 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
                               TABLE 76 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
    9.2 TRADITIONAL
           9.2.1 CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE
                    TABLE 77 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
                    TABLE 78 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
    9.3 RAPID
           TABLE 79 ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY, BY REGION, 2016–2020 (USD MILLION)
           TABLE 80 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
           TABLE 81 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2016–2020 (USD MILLION)
           TABLE 82 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2021–2026 (USD MILLION)
           9.3.1 CONVENIENCE-BASED
                    9.3.1.1 Helps detect microorganisms based on their biochemical reactions under standard growth conditions
           9.3.2 POLYMERASE CHAIN REACTION (PCR)
                    9.3.2.1 Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms
           9.3.3 IMMUNOASSAY
                    9.3.3.1 ELISA is based on the protein’s characteristic of binding to specific enzyme-labeled antibodies
           9.3.4 CHROMATOGRAPHY & SPECTROMETRY
                    9.3.4.1 Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry

10 ENTERIC DISEASE TESTING MARKET, BY REGION (Page No. - 136)
     10.1 INTRODUCTION
               FIGURE 47 REGION-WISE FOOD SAFETY EVENTS, 2020
               FIGURE 48 US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021–2026
               TABLE 83 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
               TABLE 84 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
             10.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION
                       10.1.1.1 Realistic scenario
                                   TABLE 85 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
                                   TABLE 86 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
                       10.1.1.2 Optimistic scenario
                                   TABLE 87 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
                                   TABLE 88 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
                       10.1.1.3 Pessimistic scenario
                                   TABLE 89 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
                                   TABLE 90 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
     10.2 NORTH AMERICA
               FIGURE 49 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
               TABLE 91 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
               TABLE 92 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
               TABLE 93 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
               TABLE 94 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
               TABLE 95 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
               TABLE 96 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.2.1 US
                       10.2.1.1 FSIS is the regulating body that enforces food safety regulations
                                   FIGURE 50 NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010–2018
                                   FIGURE 51 US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010–2016
                                   TABLE 97 US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016)
                                   FIGURE 52 US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016
                                   TABLE 98 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 99 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 100 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 101 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.2.2 CANADA
                       10.2.2.1 Canadian government imposed stringent regulations on exports to ensure food safety
                                   TABLE 102 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 103 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 104 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 105 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.2.3 MEXICO
                       10.2.3.1 Rise in the number of foodborne disease cases has increased focus on food safety in the country
                                   TABLE 106 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 107 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 108 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 109 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
     10.3 EUROPE
               FIGURE 53 EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013–2017
               FIGURE 54 EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
               TABLE 110 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
               TABLE 111 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
               TABLE 112 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
               TABLE 113 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
               TABLE 114 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
               TABLE 115 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.3.1 GERMANY
                       10.3.1.1 International food trade has increased food safety risks
                                   FIGURE 55 GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019
                                   TABLE 116 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 117 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 118 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 119 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.3.2 FRANCE
                       10.3.2.1 Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing
                                   TABLE 120 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 121 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 122 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 123 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.3.3 SPAIN
                       10.3.3.1 Outbreak of listeriosis will have serious implications on the Spanish meat industry
                                   TABLE 124 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 125 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 126 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 127 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.3.4 ITALY
                       10.3.4.1 Products of animal origin products are found to be more problematic in this region
                                   TABLE 128 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 129 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 130 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 131 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.3.5 POLAND
                       10.3.5.1 Increase in incidences of Salmonella outbreaks drives awareness about food safety
                                   TABLE 132 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 133 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 134 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENTS, 2016–2020 (USD MILLION)
                                   TABLE 135 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.3.6 UK
                       10.3.6.1 Norovirus infection is estimated to occur every year in the UK
                                   TABLE 136 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 137 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 138 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 139 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.3.7 REST OF EUROPE
                       TABLE 140 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                       TABLE 141 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                       TABLE 142 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                       TABLE 143 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
     10.4 ASIA PACIFIC
               TABLE 144 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)
               TABLE 145 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)
               TABLE 146 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
               TABLE 147 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
               TABLE 148 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
               TABLE 149 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.4.1 JAPAN
                       10.4.1.1 E. coli to be the major pathogen found to affect people
                                   TABLE 150 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 151 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 152 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 153 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.4.2 CHINA
                       10.4.2.1 Microbial contamination is reported to be the biggest food safety risk
                                   TABLE 154 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 155 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 156 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 157 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.4.3 INDIA
                       10.4.3.1 FSSAI to safeguard the quality of food produced
                                   TABLE 158 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 159 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 160 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 161 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.4.4 AUSTRALIA & NEW ZEALAND
                       10.4.4.1 Gastroenteritis occurs every year, affecting several people
                                   TABLE 162 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 163 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 164 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 165 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.4.5 THAILAND
                       10.4.5.1 Demand for food exports to boost the growth of the market
                                   TABLE 166 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 167 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 168 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 169 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                       TABLE 170 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                       TABLE 171 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                       TABLE 172 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                       TABLE 173 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
     10.5 SOUTH AMERICA
               TABLE 174 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
               TABLE 175 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
               TABLE 176 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
               TABLE 177 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
               TABLE 178 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET FOR FOOD END USE, BY SUBSEGMENT,2016–2020 (USD MILLION)
               TABLE 179 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.5.1 BRAZIL
                       10.5.1.1 Export of agricultural produce to boost the demand for enteric disease testing
                                   TABLE 180 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 181 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 182 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 183 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.5.2 ARGENTINA
                       10.5.2.1 Food companies are taking preventive measures for pathogen infections
                                   TABLE 184 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 185 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 186 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 187 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.5.3 REST OF SOUTH AMERICA
                       TABLE 188 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                       TABLE 189 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                       TABLE 190 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                       TABLE 191 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
     10.6 REST OF THE WORLD (ROW)
               TABLE 192 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)
               TABLE 193 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)
               TABLE 194 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
               TABLE 195 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
               TABLE 196 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
               TABLE 197 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.6.1 SOUTH AFRICA
                       10.6.1.1 Growth in the demand to follow international standards is encouraging enteric disease testing
                                   TABLE 198 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 199 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 200 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 201 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
             10.6.2 MIDDLE EAST
                       10.6.2.1 Food safety services are driven by food imports from other countries
                                   TABLE 202 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
                                   TABLE 203 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
                                   TABLE 204 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
                                   TABLE 205 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 195)
     11.1 OVERVIEW
     11.2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET
     11.3 MARKET SHARE ANALYSIS, 2020
               FIGURE 56 MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS
     11.4 COVID-19-SPECIFIC COMPANY RESPONSE
             11.4.1 SGS SA
             11.4.2 MERCK KGAA
             11.4.3 EUROFINS SCIENTIFIC
     11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 57 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS)
     11.6 PRODUCT FOOTPRINT
               TABLE 206 COMPANY FOOTPRINT, BY TECHNOLOGY
               TABLE 207 COMPANY FOOTPRINT, BY END-USE
               TABLE 208 COMPANY FOOTPRINT, BY REGION
     11.7 COMPANY EVALUATION QUADRANT (START-UP/SME)
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
                       FIGURE 58 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME)
     11.8 COMPETITIVE SCENARIO
             11.8.1 NEW PRODUCTS LAUNCHES
                       TABLE 209 ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 2019
             11.8.2 DEALS
                       TABLE 210 ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 2021
             11.8.3 OTHER DEVELOPMENTS
                       TABLE 211 ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS, MAY 2018- JUNE 2021

12 COMPANY PROFILES (Page No. - 208)
(Business overview, Products offered, Recent developments & MnM View)*
     12.1 KEY COMPANIES
             12.1.1 SGS SA
                       TABLE 212 SGS SA: BUSINESS OVERVIEW
                       FIGURE 59 SGS SA: COMPANY SNAPSHOT
                       TABLE 213 SGS SA: PRODUCT OFFERINGS
                       TABLE 214 SGA SA: DEALS
                       TABLE 215 SGS SA: OTHERS
             12.1.2 MERCK KGAA
                       TABLE 216 MERCK KGAA: BUSINESS OVERVIEW
                       FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT
                       TABLE 217 MERCK KGAA: PRODUCT OFFERINGS
             12.1.3 THERMO FISHER SCIENTIFIC INC.
                       TABLE 218 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
                       FIGURE 61 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
                       TABLE 219 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
                       TABLE 220 THERMO FISHER SCIENTIFIC INC.: DEALS
             12.1.4 EUROFINS SCIENTIFIC
                       TABLE 221 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                       FIGURE 62 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
                       TABLE 222 EUROFINS SCIENTIFIC: PRODUCT OFFERINGS
                       TABLE 223 EUROFINS SCIENTIFIC: DEALS
                       TABLE 224 EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS
             12.1.5 ALS LIMITED
                       TABLE 225 ALS LIMITED: BUSINESS OVERVIEW
                       FIGURE 63 ALS LIMITED: COMPANY SNAPSHOT
                       TABLE 226 ALS LIMITED: PRODUCT OFFERINGS
                       TABLE 227 ALS LIMITED: DEALS
                       TABLE 228 ALS LIMITED: OTHER DEVELOPMENTS
             12.1.6 ASURE QUALITY
                       TABLE 229 ASURE QUALITY: BUSINESS OVERVIEW
                       FIGURE 64 ASURE QUALITY: COMPANY SNAPSHOT
                       TABLE 230 ASURE QUALITY: PRODUCT OFFERINGS
             12.1.7 BUREAU VERITAS
                       TABLE 231 BUREAU VERITAS: BUSINESS OVERVIEW
                       FIGURE 65 BUREAU VERITAS: COMPANY SNAPSHOT
                       TABLE 232 BUREAU VERITAS: PRODUCT OFFERINGS
             12.1.8 INTERTEK
                       TABLE 233 INTERTEK: BUSINESS OVERVIEW
                       FIGURE 66 INTERTEK: COMPANY SNAPSHOT
                       TABLE 234 INTERTEK: PRODUCT OFFERINGS
                       TABLE 235 INTERTEK: DEALS
             12.1.9 BIO-RAD LABORATORIES, INC.
                       TABLE 236 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                       FIGURE 67 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
                       TABLE 237 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
             12.1.10 BECTON DICKINSON
                       TABLE 238 BECTON DICKINSON: BUSINESS OVERVIEW
                       FIGURE 68 BECTON DICKINSON: COMPANY SNAPSHOT
                       TABLE 239 BECTON DICKINSON: PRODUCT OFFERINGS
             12.1.11 3M
                       TABLE 240 3M: BUSINESS OVERVIEW
                       FIGURE 69 3M: COMPANY SNAPSHOT
                       TABLE 241 3M: PRODUCT OFFERINGS
             12.1.12 PERKINELMER, INC.
                       TABLE 242 PERKINELMER, INC.: BUSINESS OVERVIEW
                       FIGURE 70 PERKINELMER, INC.: COMPANY SNAPSHOT
                       TABLE 243 PERKINELMER, INC.: PRODUCT OFFERINGS
             12.1.13 NEOGEN CORPORATION
                       TABLE 244 NEOGEN CORPORATION: BUSINESS OVERVIEW
                       FIGURE 71 NEOGEN CORPORATION: COMPANY SNAPSHOT
                       TABLE 245 NEOGEN CORPORATION: PRODUCT OFFERINGS
             12.1.14 MΙRIEUX NUTRISCIENCES
                       TABLE 246 MΙRIEUX NUTRISCIENCES: BUSINESS OVERVIEW
                       TABLE 247 MΙRIEUX NUTRISCIENCES: PRODUCT OFFERINGS
                       TABLE 248 MΙRIEUX NUTRISCIENCES: DEALS
             12.1.15 TάV SάD
                       TABLE 249 TάV SάD: BUSINESS OVERVIEW
                       TABLE 250 TάV SάD: PRODUCT OFFERINGS
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
     12.2 OTHER PLAYERS
             12.2.1 HARDY DIAGNOSTICS
                       TABLE 251 HARDY DIAGNOSTICS: BUSINESS OVERVIEW
                       TABLE 252 HARDY DIAGNOSTICS: PRODUCT OFFERINGS
                       TABLE 253 HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH
             12.2.2 ROMER LABS
                       TABLE 254 ROMER LABS: BUSINESS OVERVIEW
                       TABLE 255 ROMER LABS: PRODUCT OFFERINGS
             12.2.3 NOVA BIOLOGICALS
                       TABLE 256 NOVA BIOLOGICALS: BUSINESS OVERVIEW
                       TABLE 257 NOVA BIOLOGICALS: PRODUCT OFFERINGS
             12.2.4 SYMBIO LABORATORIES
                       TABLE 258 SYMBIO LABORATORIES: BUSINESS OVERVIEW
                       TABLE 259 SYMBIO LABORATORIES: PRODUCT OFFERINGS
             12.2.5 CERTIFIED LABORATORIES

13 ADJACENT AND RELATED MARKETS (Page No. - 257)
     13.1 INTRODUCTION
               TABLE 260 ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET
     13.2 LIMITATIONS
     13.3 FOOD PATHOGEN TESTING MARKET
             13.3.1 MARKET DEFINITION
             13.3.2 MARKET OVERVIEW
                       TABLE 261 E. COLI MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
                       TABLE 262 SALMONELLA MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
                       TABLE 263 CAMPYLOBACTER MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
                       TABLE 264 LISTERIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
     13.4 FOOD TESTING KITS MARKET
             13.4.1 MARKET DEFINITION
             13.4.2 MARKET OVERVIEW
                       TABLE 265 FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD PRODUCTS, BY REGION, 2015–2022 (USD MILLION)
                       TABLE 266 FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2015–2022 (USD MILLION)
                       TABLE 267 FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION, 2015–2022 (USD MILLION)
                       TABLE 268 FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015–2022 (USD MILLION)
     13.5 MICROBIAL WATER TESTING MARKET
             13.5.1 MARKET DEFINITION
             13.5.2 MARKET OVERVIEW
                       TABLE 269 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015–2022 (USD MILLION)
                       TABLE 270 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
                       TABLE 271 DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
                       TABLE 272 INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)

14 APPENDIX (Page No. - 265)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

The study involved four major activities in estimating the enteric disease testing market size. Exhaustive secondary research was conducted to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

In the secondary research process, various sources, such as the Food and Agriculture Organization (FAO), Enteric disease Council (FSC), The European Federation of National Associations of Measurement, Testing, and Analytical Laboratories (EUROLAB), European Enteric disease Authority (EFSA), Food Standards Australia New Zealand (FSANZ), and Canadian Food Inspection Agency (CFIA) were referred to identify and collect information for this study. The secondary sources also include clinical studies and medical journals, press releases, investor presentations of companies, white papers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases.

Secondary research was mainly conducted to obtain critical information about the industry’s supply chain, the total pool of key players, and market classification & segmentation according to the industry trends to the bottom-most level, and geographical markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information. The primary sources from the supply side included industry experts, such as CEOs, vice presidents, service providers, technology and innovation directors, and related key executives from various key companies and organizations operating in the enteric disease testing market.

Post completion of market engineering (which included calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and to verify and validate the critical numbers arrived at. Primary research conducted aided in identifying and ratifying the segmentation types, industry trends, key players, competitive landscape of enteric disease testing services supplied by different types of market players, and key market dynamics, such as drivers, restraints, opportunities, industry trends, and key player strategies.

Enteric Disease Testing Market Primary Respondents

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches have been used to estimate and validate the total size of the market. These approaches have also been used extensively to estimate the size of various dependent submarkets. The research methodology used to estimate the market size includes the following details:

Top-Down

  • Calculations for the market size have been based on the revenues of key companies identified in the market, which dominated the overall market size. This overall market size has been used in the top-down procedure to estimate the size of other individual markets (mentioned in the market segmentation) via percentage splits derived using secondary and primary sources.
  • All macroeconomic and microeconomic factors such as the number of food recall, cases of contaminations, growth in the number of infectious diseases through enteric disease-causing pathogens that affect the growth of the enteric disease testing market were considered while estimating the market size.
  • Further analysis of the revenue from each of the product categories was analyzed to understand the share of enteric disease testing in the food and water industries.
  • The market size, regional, and segmental market shares so obtained were validated with key primary respondents in the enteric disease testing market.

Bottom-Up

  • The bottom-up approach was implemented for the data extracted from secondary research to validate the share of the market segments obtained.
  • The approach aided in understanding the trend of food applications for which enteric disease testing was adopted at a country level. This was done by analyzing the data on food recalls within different food categories such as meat, poultry, dairy products, and processed foods in each country due to microbial contamination. These were individually added up for each country to arrive at the global and regional market size and CAGR.
  • By at a country level
  • The bottom-up procedure has been employed to arrive at the overall size of the enteric disease testing market from the revenues of key players (companies) and their product share in the market at a country level.

Global Enteric disease testing Market Size: Methodology

Enteric Disease Testing Market Methodology

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using the top-down and bottom-up approaches.

Report Objectives

  • Determining and projecting the size of the enteric disease testing market with respect to pathogen, end use, technology, and region, over five years ranging from 2021 to 2026.
  • Identifying the attractive opportunities in the market by determining the largest and fastest-growing segments across the key regions
  • Analyzing the demand-side factors on the basis of the following:
    • Impact of macro- and micro-economic factors on the market
    • Shifts in demand patterns across different subsegments and regions
  • Identifying and profiling the key market players in the enteric disease testing market
  • Determining the market share of key players operating in the enteric disease testing market
  • Providing a comparative analysis of the market leaders on the basis of the following:
    • Service offerings
    • Business strategies
    • Strengths and weaknesses
    • Key financials
  • Understanding the competitive landscape and identifying the major growth strategies adopted by players across the key regions

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to the company’s specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

  • With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
  • Further breakdown of the enteric disease testing market in Rest of Europe, which includes countries such as Belgium, Russia, Denmark, Hungary, and Sweden
  • Further breakdown of the enteric disease testing market in Rest of Asia Pacific, which includes countries such as Indonesia, South Korea, Malaysia, the Philippines, and Vietnam
  • Further breakdown of the enteric disease testing market in Rest of South America, which includes countries such as Peru and Uruguay

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Enteric Disease Testing Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Enteric Disease Testing Market

Request For Special Pricing
Report Code
FB 7970
Published ON
Aug, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Enteric Disease Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved